MIRA MIRA Pharmaceuticals, Inc.
$0.77▼ -1.95%
Healthcare
Other
After hours
$0.78▲ +0.79%
Sep 11, 7:02 PM ET
Volume 105.5K
Avg Volume (10D) 3.12M
Key Metrics & Fundamentals
Market Cap
$32.52M
P/E Ratio
–
Div Yield
–%
52W Range
0.60 - 2.45
% vs 50 MA
-5.43%
% vs 200 MA
-29.57%
RSI-14
48.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.84
Free Cash Flow
-$1.21M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.16M
COGS
–
Operating Exp
$1.16M
Operating Income
-$1.16M
EBIT
-$1.16M
Pretax Income
-$1.21M
Net Income
-$1.21M
EPS (Diluted)
-0.03
Price & Volume History
Loading chart…
Recent News
Landmark 2026 Clinical Study Validates At-Home Quantitative Multi-Hormone Monitoring Against Ultrasound Gold Standard
PR Newswire · Sep 1, 2026 12:04 PM
MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
GlobeNewswire · Sep 1, 2026 12:00 PM
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
Stocktwits · Aug 6, 2026 1:19 PM
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
GlobeNewswire · Jul 30, 2026 12:00 PM
Mira Pharmaceuticals Oral Form Shows 'Positive' Results in Pre-Clinical Studies
MT Newswires · Jul 10, 2026 12:33 PM
MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain
ACCESS Newswire · Jul 10, 2026 12:00 PM
Clockwork.ai Launches Mira: The AI Giving 3,000+ Businesses a CFO They Could Never Afford
PR Newswire · Jul 8, 2026 2:26 PM
Mira Pharmaceuticals Says SKNY-1 in Obesity, Addiction Shows 'Favorable' Bioavailability in Preclinical Studies
MT Newswires · Jul 6, 2026 1:44 PM
MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction
ACCESS Newswire · Jul 6, 2026 1:00 PM
MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC
ACCESS Newswire · Jun 25, 2026 12:15 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MIRA's money flow as a full page
Social Sentiment
Avg +0.54 · 10 posts
NewsDiscussionIf You Don't Think AI is Very Bubbly...
r/investing · Jun 25, 2025
The post is highly critical of the company's lack of product and questionable valuation, reflecting a negative sentiment.
negative
-0.60
NewsDiscussionMIRA - Pharmaceuticals shares trading higher after efficacy results from Ketamir in its diabetes-associated nerve damage
r/wallstreetbets · Apr 16, 2025
Significant stock price increase (25%) following positive efficacy results and planned clinical trials indicate strong bullish sentiment.
very_positive
+1.00
NewsTradePriceTargetMIRA - MIRA PHARMACEUTICALS Says Diabetes Treatment Ketamir-2 Shows Significant Reduction in Neuropathic Pain Symptoms in Animal Model
r/wallstreetbets · Apr 16, 2025
Significant share price increase (35%) and positive clinical trial results suggest a very bullish sentiment.
very_positive
+1.00
DiscussionJust joined Mira, let's make it the new piece of pi! Add me MNS0928
r/wallstreetbets · Mar 6, 2025
The post is an enthusiastic introduction and comparison, suggesting a positive outlook.
positive
+0.60
DDNewsDiscussionMIRA. A HOLDER TILL 2030?
r/wallstreetbets · Dec 17, 2024
The post is a detailed discussion about MIRA's prospects, pipeline, and potential, indicating optimism.
positive
+0.70
Page 1 of 2 (10 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.